Safety Profile of Sinopharm COVID-19 Vaccine and Breakthrough Infections in Pakistan. Annals KEMU [Internet]. 2022 Jan. 27 [cited 2024 May 4];27(4). Available from: https://www.annalskemu.org/journal/index.php/annals/article/view/4884